| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,242 |
10,709 |
$331K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,934 |
1,647 |
$75K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,396 |
1,186 |
$30K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
656 |
572 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,739 |
1,466 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,182 |
716 |
$18K |
| 99490 |
Ccm add 20min |
564 |
556 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,052 |
960 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
2,480 |
2,285 |
$11K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
274 |
262 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
578 |
477 |
$10K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
370 |
303 |
$6K |
| 99439 |
|
190 |
187 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
123 |
100 |
$3K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
241 |
233 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
39 |
37 |
$2K |
| 90674 |
|
105 |
95 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
135 |
126 |
$1K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
59 |
58 |
$727.57 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
87 |
76 |
$436.80 |
| 87807 |
|
35 |
33 |
$363.59 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
59 |
54 |
$334.55 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
30 |
29 |
$230.71 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
74 |
69 |
$218.06 |
| 80305 |
|
17 |
17 |
$128.78 |
| 97802 |
|
16 |
15 |
$105.02 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
17 |
14 |
$46.35 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
1,711 |
1,459 |
$14.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20 |
13 |
$8.58 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
799 |
667 |
$0.00 |
| G8419 |
Bmi documented outside normal parameters, no follow-up plan documented, no reason given |
138 |
121 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
91 |
79 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
16 |
15 |
$0.00 |